High Purity Research Peptides: What the Number Means

High purity research peptides are synthetic peptides whose lab report shows a high HPLC purity, usually 95% or more and often above 98%, measured as the main peak’s share of the UV-absorbing, peptide-related signal at 214 or 220 nm. That figure is relative. It does not confirm which molecule the main peak is, how much peptide the vial holds, or how much of the powder is counter-ion and water. A complete purity claim pairs the HPLC figure with identity by mass spectrometry and a stated net content.

This article explains what the purity number measures, the four things it leaves out, the specification limits commonly seen, how to check a claim, and what eight real lot reports show.

High purity at a glance

Source: summarised from the analytical literature cited below [1-8].

Research materials: Vortex Research publishes its third-party lab reports, each with its chromatogram and a lab-portal verification link, at /coa/.

What “high purity” means on a lab report

On almost every peptide certificate of analysis, purity comes from reversed-phase high-performance liquid chromatography (RP-HPLC) with UV detection. The sample is separated on a hydrophobic column, and the detector draws one peak for each separated component. Software integrates the peaks and reports:

Purity (%) = main peak area ÷ total area of the integrated peptide-related peaks × 100

So “99.5% pure” means that 99.5% of the integrated, UV-absorbing peptide signal came from one peak, under that method’s conditions. Our explainer on HPLC peptide purity covers the columns, solvents and integration rules behind the figure. If the term COA is new, start with what a COA is.

Two properties of the measurement matter for reading a “high purity” claim:

• It depends on the method. In a systematic comparison of synthetic peptide standards that differed at one position, n-alkyl C18, polar-embedded and polar-endcapped columns showed profound differences in selectivity, and switching the organic solvent from acetonitrile to methanol changed it further [1]. An impurity that separates on one column can hide under the main peak on another.
• UV response is not identical between molecules. At 214 nm the peptide bond absorbs at 923 M-1 cm-1, tryptophan about 30 times more, and phenylalanine, tyrosine and histidine about six times more [2]. An impurity with an extra or a missing aromatic residue gives a peak area that does not match its true share.

For close relatives of the main peptide, such as a sequence missing one residue, these effects are usually small. They are the reason a purity figure belongs to a method and should come with its chromatogram.

Common purity specifications for research peptides

There is no single standard that defines “high purity”. What exists are specification limits, set by whoever orders or issues the report. In custom peptide synthesis, purity is usually sold in tiers: crude (unpurified), then purified grades with stated minimums such as 70%, 80%, 90%, 95% and 98%. The higher tiers need more preparative HPLC, and some sequences are hard to purify past a given level at all.

Source: Vortex Research Editorial Team, from common custom-synthesis grade conventions; the 95.0% limit is the specification printed on the ILS Laboratories MOTS-C report discussed below.

Pharmacopoeial monographs for peptide drug substances go further. They specify identification, purity and assay (content) as separate tests with separate acceptance criteria, and a review of those monographs found the specifications differ markedly between the European Pharmacopoeia and the United States Pharmacopeia [3]. A purity figure alone, however high, is one of those three attributes.

What a high HPLC purity figure leaves out

1. Identity

A synthesis of the wrong sequence can be 99% pure. UV detection counts components; it does not name them. Identity needs a measured mass, typically by electrospray mass spectrometry, which produces intact, often multiply charged ions whose mass-to-charge ratios can be compared with values calculated from the expected formula [4]. A weaker alternative is a retention-time match against a reference standard. Even mass alone cannot separate isomers of identical mass, such as diastereomers.

2. Related impurities that co-elute

Synthetic peptides carry characteristic impurities: deletion and insertion sequences, diastereomers from racemisation, side-chain protection adducts, oxidised forms, dimers and, in some documented cases, unrelated peptides [5]. Any of these that leave the column at the same time as the main peak are counted as main peak. Diastereomers are the classic example, because they are nearly identical in hydrophobicity.

3. Counter-ions

Solid-phase peptide synthesis uses trifluoroacetic acid (TFA) to cleave the peptide from the resin, and RP-HPLC purification uses it again as an ion-pairing agent, so purified peptides are commonly obtained as TFA salts [7]. The counter-ion does not appear as a peptide peak at 214 nm. It is invisible to area-percent purity, yet it is part of the mass of the powder.

How large can that share be? In a purity assignment for a candidate certified reference material of the peptide angiotensin II, the TFA counter-ion, measured by validated 19F quantitative NMR, was nearly 25% of the mass. The final assigned purity of the material, combining a mass-balance approach with qNMR and amino acid analysis, was 691 ± 9 mg/g [6], or about 69% peptide. Even a material being characterised as a reference standard was roughly two-thirds peptide by mass.

Counter-ions also matter for experiments. In a study that exchanged TFA for chloride by freeze-drying peptides from hydrochloric acid, exchange with 10 mM HCl worked best and did not change peptide purity, while passive permeability through liposome membranes differed with sequence and salt form; the authors stressed counter-ion quantification and specification for assays with synthetic peptides [7].

4. Water and residual salts

Lyophilised peptides hold bound water and take up more from air. Water does not register in an HPLC purity figure. Moisture content is also one of the main factors in solid-state chemical reactions of peptides, alongside temperature and excipients: deamidation, oxidation, peptide bond cleavage and aggregation all proceed in the dry state [8]. Our explainer on lyophilised peptides covers why the material is kept sealed and dry.

Net content: the number that completes a purity claim

If purity says how clean the peptide signal is, net content says how much peptide is actually there. Labs use different approaches:

• Amino acid analysis. The peptide is hydrolysed, typically in 6 M hydrochloric acid, and the released amino acids are quantified. Peptide content follows from the known sequence. A 2023 method quantified 17 underivatised amino acids by RP-LC with multiple reaction monitoring MS against isotope-labelled internal standards, without derivatisation [9].
• Mass balance. Purity is assigned by subtracting the measured mass fractions of everything that is not the peptide: related peptides, counter-ions, water and residual solvents [6].
• Quantitative NMR or HPLC against a reference standard. The intact peptide is measured directly against a standard of known content.

Reference-standard producers combine several of these. Work from the United States Pharmacopeial Convention describes assigning a mass-balance value to bulk peptide material first, then using that bulk as the standard for the vialed lots [10]. A routine third-party report does not repeat that work, but its net content result is only as good as the standard behind it.

Some research-peptide reports express net content as a percentage of powder mass. Others, including the reports below, give milligrams of peptide per vial. Neither form is wrong, but a reader should know which is printed, and the lab is the place to ask about the method.

Why purity matters in research data

Purity is not an abstract quality score. A small contaminant can produce a real signal. In one documented case, peptide library sets bought from two independent custom suppliers contained contaminating peptides; analysis of one original stock found about 1% by mass of a peptide commonly used in cellular immunology research, enough to give false-positive readings in T-cell assays [11]. The authors proposed adding biological quality checks to the standard analytical ones. The general lesson is that a purity figure describes the main component, and the remaining fraction is not necessarily inert.

How to check a “high purity” claim

1. Find the method. The report should name RP-HPLC, the wavelength (214 or 220 nm) and ideally the column and gradient.
2. Look at the chromatogram. One dominant, symmetrical peak on a flat baseline is the expected picture. A shoulder or a split top can mean an unresolved impurity.
3. Check identity separately. Look for an expected and an observed mass, or at least a retention-time match against a named reference standard.
4. Read the specification. “99.4% against a minimum of 95.0%” is a pass with margin. A bare number has no context.
5. Find net content. Purity without content says nothing about how much peptide is in the vial.
6. Match the lot. The report should carry the lot or batch code on the vial.
7. Verify at the lab. Retrieve the original from the lab’s own portal and compare it with the seller’s copy.

Our field-by-field explainer on reading a peptide COA works through these steps on two real reports.

Real lot figures: what eight reports show

Source: lab reports as published on vortexresearch.net/coa/, read October 21, 2026. “Partner facility” reports were issued by ILS Laboratories to Vortex’s wholesale partner facility for the batch Vortex stocks, and are labelled as such on the page. Across all reports published there, HPLC purity ranges from 98.04% to 99.97%.

Four points stand out:

• The peptide results sit well above a 95% minimum. The MOTS-C report prints a 95.0% specification; the six peptide results run from 99.18% to 99.94%.
• Identity is mostly by retention time. Only the GHK-Cu report confirms identity by LC-MS, with observed ions that match the calculated mass of the GHK chain. The others compare retention time with a reference standard, which is a weaker test, as set out above.
• Net content is a mass per vial and runs above the label. The peptide results are 103% to 110% of label. Overfill and quantitation uncertainty both contribute, and none of the reports states the quantitation method or the counter-ion form.
• A blend gets one purity figure but two contents. The BPC-157 + TB-500 report gives one purity value for the vial and a separate content for each peptide. A report on a blend should identify each component separately.

Two lot fields are weak. “Purple cap” on the MOTS-C report names a cap colour, not a batch code. Partner-facility reports tie the tested batch to Vortex’s stock through the batch code and Vortex’s statement, not through a sample Vortex sent itself. Both points are disclosed on the COA page. For how the impurities in the table’s small remaining fractions arise, see how peptides are made.

Frequently asked questions

What does high purity mean for research peptides?

It usually means a lab report shows HPLC purity of 95% or more, often above 98%. The figure is the main peak’s share of the UV-absorbing, peptide-related signal at 214 or 220 nm. It does not by itself confirm identity or how much peptide is in the vial.

Is 99% HPLC purity the same as 99% peptide content?

No. HPLC purity ignores water, counter-ions and salts, which do not appear as peptide peaks. In one certified reference material of angiotensin II, the trifluoroacetate counter-ion alone was nearly 25% of the mass, and the assigned purity was about 69% peptide by mass.

What purity should a research peptide have?

There is no universal standard. A minimum of 95% is a common specification on third-party reports for purified research peptides, and custom synthesis offers tiers from crude up to 98% or more. The right level depends on the experiment, and the figure should come with identity data and net content.

How can a purity claim be verified?

Retrieve the original report from the testing lab’s own portal using its report number or access code, and compare it with the seller’s copy. Then check the method, the chromatogram, the specification, the identity result, the net content and the lot code.

Research materials: Vortex Research supplies peptides as sealed lyophilised research reagents. Browse the catalogue at /shop/. Published lab reports, with chromatograms and lab-portal verification links, are at /coa/.

References

1. Mant CT, Cepeniene D, Hodges RS. Reversed-phase HPLC of peptides: assessing column and solvent selectivity on standard, polar-embedded and polar endcapped columns. J Sep Sci. 2010;33(19):3005-21. PMID 21038458. doi:10.1002/jssc.201000518
2. Kuipers BJ, Gruppen H. Prediction of molar extinction coefficients of proteins and peptides using UV absorption of the constituent amino acids at 214 nm to enable quantitative reverse phase high-performance liquid chromatography-mass spectrometry analysis. J Agric Food Chem. 2007;55(14):5445-51. PMID 17539659. doi:10.1021/jf070337l
3. Vergote V, Burvenich C, Van de Wiele C, De Spiegeleer B. Quality specifications for peptide drugs: a regulatory-pharmaceutical approach. J Pept Sci. 2009;15(11):697-710. PMID 19750489. doi:10.1002/psc.1167
4. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science. 1989;246(4926):64-71. PMID 2675315. doi:10.1126/science.2675315
5. D’Hondt M, Bracke N, Taevernier L, et al. Related impurities in peptide medicines. J Pharm Biomed Anal. 2014;101:2-30. PMID 25044089. doi:10.1016/j.jpba.2014.06.012
6. Melanson JE, Thibeault MP, Stocks BB, Leek DM, McRae G, Meija J. Purity assignment for peptide certified reference materials by combining qNMR and LC-MS/MS amino acid analysis results: application to angiotensin II. Anal Bioanal Chem. 2018;410(26):6719-6731. PMID 30143839. doi:10.1007/s00216-018-1272-7
7. Erckes V, Streuli A, Chamera Rendueles L, Krämer SD, Steuer C. Towards a consensus for the analysis and exchange of TFA as a counterion in synthetic peptides and its influence on membrane permeation. Pharmaceuticals (Basel). 2025;18(8):1163. PMID 40872554. doi:10.3390/ph18081163
8. Lai MC, Topp EM. Solid-state chemical stability of proteins and peptides. J Pharm Sci. 1999;88(5):489-500. PMID 10229638. doi:10.1021/js980374e
9. Qasrawi DO, Petrotchenko EV, Borchers CH. Amino acid analysis for peptide quantitation using reversed-phase liquid chromatography combined with multiple reaction monitoring mass spectrometry. Anal Bioanal Chem. 2023;415(22):5261-5267. PMID 37468754. doi:10.1007/s00216-023-04840-2
10. McCarthy D, Han Y, Carrick K, et al. Reference standards to support quality of synthetic peptide therapeutics. Pharm Res. 2023;40(6):1317-1328. PMID 36949371. doi:10.1007/s11095-023-03493-1
11. Currier JR, Galley LM, Wenschuh H, et al. Peptide impurities in commercial synthetic peptides and their implications for vaccine trial assessment. Clin Vaccine Immunol. 2008;15(2):267-76. PMID 18077621. doi:10.1128/CVI.00284-07

Methods note: written by the Vortex Research Editorial Team. Lot figures were read from the lab reports published on vortexresearch.net/coa/ on October 21, 2026. Literature was selected from PubMed for analytical chemistry topics, and every PMID was checked against its PubMed record and abstract.

Vortex Research products are sold for in-vitro laboratory research by qualified researchers. Not for human or veterinary use. Not a drug, dietary supplement or cosmetic. Statements have not been evaluated by the FDA.